StockData
GoodRx Holdings, Inc. logo

GoodRx Holdings, Inc. (GDRX) stock

GDRXNasdaqServices-Computer Processing & Data PreparationFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 11/3037% below fair value
$3.47−0.04 (-1.14%)

Close on Nov 17, 2026Market cap $1.18BP/E 86.8Yield –

GoodRx enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

GoodRx's enterprise value was $1.45B on Nov 11, 2026, against $1.25B a year earlier. Over the last 5 years it ranged from $893.98M to $13.11B, with a median of $2.09B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.45B+19.5%
2025Dec 31, 2025$1.21B-35.3%
2024Dec 31, 2024$1.88B-28.6%
2023Dec 29, 2023$2.63B+46.1%
2022Dec 30, 2022$1.80B-86.3%
2021Dec 31, 2021$13.11B+42.9%
2020Dec 31, 2020$9.17B–

More GoodRx figures

See a number that looks wrong?